Home > Insider Trading > Filing (0001401708-21-000120)

Filing Details

Accession Number:: 0001401708-21-000120
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-04-13 19:53:51
Reporting Period:: 2021-03-10

Accepted Time:: 2021-04-13 19:53:51
Original Submission Date:: 2021-03-12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401708	Nanostring Technologies Inc	NSTG	Biological Products, (No Disgnostic Substances) (2836)	200094687

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575739	Bradley R Gray	530 Fairview Avenue N Seattle WA 98109	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-10	8,631	$1.92	146,138	No	4	M	Direct
Common Stock	Acquisiton	2021-03-10	16,369	$6.72	162,507	No	4	M	Direct
Common Stock	Disposition	2021-03-10	10,261	$61.09	152,246	No	4	S	Direct
Common Stock	Disposition	2021-03-10	14,890	$62.02	137,356	No	4	S	Direct
Common Stock	Disposition	2021-03-10	6,082	$63.07	131,274	No	4	S	Direct
Common Stock	Disposition	2021-03-10	2,100	$63.88	129,174	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

On March 12, 2021, the Reporting Person filed a Form 4 which inadvertently misstated the number of shares held by the Reporting Person following the exercise of stock options and sale of shares of Common Stock reported on the Form 4. The number of shares reported in Column 5 of this Form 4/A reflects the corrected amounts of securities beneficially owned by the Reporting Person following the previously reported transactions as of the date of each such transaction.
The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2020.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $60.55 to $61.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $61.55 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $62.55 to $63.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $63.59 to $64.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.